Sentinel node biopsy in breast cancer-A need for randomized trials

Breast

Volumn 10, Issue 4, 2001, Pages 279-280

  Mansel, R E ^a   Clarke, D ^a  

^a University Department of Surgery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; RADIOPHARMACEUTICAL AGENT; TECHNETIUM SULFUR COLLOID TC 99M;

ARTICLE; BREAST CANCER; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; HEALTH ECONOMICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MORBIDITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; STAINING; STANDARD; SURGEON; SURGICAL TECHNIQUE;

EID: 0034916041     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2001.0295     Document Type: Article

References (14)

1. Relation of number of positive nodes to the prognosis of patients with primary breast cancer. An NSABP update
2. The sentinel node and breast cancer
3. Sentinel-lymph-node biopsy in breast cancer
4. Sentinel node biopsy in breast cancer
5. Surgical resection and radiolocalisation of the sentinel node in breast cancer using a gamma probe
6. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
7. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center
8. Mammary lymphoscintigraphy in breast cancer
9. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes
10. Sentinel node biopsy in 70 unselected patients with breast cancer: Increased feasibility by using 10mCi radiocolloid in combination with a blue dye tracer
11. Technique of selected resection of radiolabelled nodes in breast cancer patients
12. Lymphatic mapping and sentinel node biopsy in breast cancer
13. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma
14. Improved axillary staging of breast cancer with sentinel lymphadenectomy